Literature DB >> 5165124

Participation of three cell types in the anti-sheep red blood cell response in vitro. Separation of antigen-reactive cells from the precursors of antibody-forming cells.

T Tan, J Gordon.   

Abstract

Spleen cells of unprimed CBA mice were shown to produce anti-sheep red blood cell antibodies comparable in amount in vivo and in vitro. Under identical culture conditions spleen cells of C57BL mice did not respond. CBA spleen cells, passed through columns of cotton wool (CBAf), were equally inactive in vitro. However combined cultures containing both CBAf and C57BL cells yielded as many or more plaque-forming cells than the same number of unfractionated CBA spleen cells. Analysis of the contribution of each cell population to the synthesis of antibody in the combined cultures has disclosed the participation of three cell types. A thymus-dependent, radiosensitive cell was derived from the CBAf population, while the C57BL was the source of the precursor of the antibody-forming cell and of a radioresistant cell. The latter two were partially separated in a Staput apparatus.

Entities:  

Mesh:

Year:  1971        PMID: 5165124      PMCID: PMC2138949          DOI: 10.1084/jem.133.3.520

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Primary immune response in cultures of spleen cells.

Authors:  J Marbrook
Journal:  Lancet       Date:  1967-12-16       Impact factor: 79.321

Review 2.  Cell interaction in antibody synthesis.

Authors:  D W Talmage; H Hemmingsen
Journal:  J Allergy       Date:  1969-06

3.  Role of monocytes in the mixed leukocyte culture reaction.

Authors:  J Gordon
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

4.  Immunological studies on the rat thymectomized in adult life.

Authors:  H F Jeejeebhoy
Journal:  Immunology       Date:  1965-11       Impact factor: 7.397

5.  Separation of cells by velocity sedimentation.

Authors:  R G Miller; R A Phillips
Journal:  J Cell Physiol       Date:  1969-06       Impact factor: 6.384

6.  Thymus-marrow cell combinations. Synergism in antibody production.

Authors:  H N Claman; E A Chaperon; R F Triplett
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

7.  Fractionation of splenic antibody-forming cells on glass bead columns.

Authors:  P H Plotz; N Talal
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

8.  A requirement for two cell types for antibody formation in vitro.

Authors:  D E Mosier
Journal:  Science       Date:  1967-12-22       Impact factor: 47.728

9.  The mitotic response of thymus-derived cells to antigenic stimulus.

Authors:  A J Davies; E Leuchars; V Wallis; P C Koller
Journal:  Transplantation       Date:  1966-07       Impact factor: 4.939

10.  Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes.

Authors:  J F Miller; G F Mitchell
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

View more
  5 in total

1.  The T cell-dependent period of the immune response to sheep erythrocytes.

Authors:  W B Van Muiswinkel; P L Van Soest
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

2.  Depression of contact sensitivity and enhancement of antibody response in Pseudomonas aeruginosa-infected mice.

Authors:  M Campa; C Garzelli; G Falcone
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

3.  Cell interactions in the immune response in vitro. II. The requirement for macrophages in lymphoid cell collaboration.

Authors:  M Feldmann
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307

4.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

5.  Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s).

Authors:  I Gery; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.